	Combination therapy
Breast cancer
Letrozole
Adjuvant therapy
Mechanism of resistance
Postmenopausal
Aromatase inhibitors
	combination therapy
growth factor
breast tumors
tumor biology
therapy
tyrosine kinase
cells
clinical
letrozole
tamoxifen
pathways
studies
potent AIs
tumors
combination
resistance
growth
alternative intracellular
signal transduction
patients
treatment
agents
biomarkers
Gene expression analysis
recent advances
effective
ER overexpression
hormone-resistant tumors
gene
Microarray gene
expression
predictive factors
trial
trastuzumab
randomized
tool
intensively
metastatic
Cancer
target
estrogen
high levels

